Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420657Aexternal-prioritypatent/GB9420657D0/en
Application filed by Nycomed Imaging AsfiledCriticalNycomed Imaging As
Priority claimed from PCT/GB1995/000899external-prioritypatent/WO1995028967A1/en
Publication of MXPA96004901ApublicationCriticalpatent/MXPA96004901A/es
Publication of MX9604901ApublicationCriticalpatent/MX9604901A/es
La invencion proporciona un agente de contraste para combinado sanguíneo que tiene una porcion molecular completa de al menos 10 KD, que comprende una macroestructura que tiene unida a ésta una pluralidad de porciones inhibidoras de la opsonizacion y posee porciones paramagnéticas ionicas o de un metal pesado, queladas, los grupos quelantes para dichas porciones queladas son macrocíclicos, donde la macroestructura es liposomal.
MX9604901A1994-10-131995-04-20Agentes de contraste.
MX9604901A
(es)
Five-membered heterocycles having biphenylsulfonylsubstitution, process for their prparation, their use as a medicament or diagnostic, and medicament .